Nationwide registry for catheter ablation treatment of cardiac arrhythmias in Japan

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Japanese Catheter Ablation Registry is a voluntary nationwide observational registry aimed at collecting and analyzing data on catheter ablation treatments for cardiac arrhythmias across Japan. Conducted by the Japanese Heart Rhythm Society in collaboration with the National Cerebral and Cardiovascular Center, this registry utilizes a Research Electronic Data Capture (REDCap) system for prospective data collection. It focuses on documenting the acute success rates, complications, and various predictive factors associated with catheter ablation procedures. Data is collected annually, providing valuable insights into the effectiveness and safety of these treatments in Japanese arrhythmia units.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients treated with catheter ablation in Japan

Exclusion Criteria:

* Patients who refused to consent

Where it's running

• National Cerebral and Cardiovascular Center
  Suita, Osaka, Japan Recruiting

Study contacts

• Principal investigator: Teiichi Yamane, MD, PhD — The Jikei University School of Medicine
• Study coordinator: Kengo Kusano, MD, PhD
• Email: kusanokengo@ncvc.go.jp
• Phone: +81-6-6170-1070

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predict Arrhythmia Risk with Intelligent Software

  Researchers are testing AI-powered predictions to see if clinicians can spot patients at risk for dangerous heart rhythms using bedside ECG data.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07792694

• Non-invasive mapping to help treat ventricular tachycardia due to heart disease

  This study tests a non-invasive mapping tool to guide VT ablation in adults with structural heart disease and prior heart attack.

  Recruiting at 2 sites University of Warwick · Brighton and 2 other locations · NCT07759427

• Rhythm control for device-detected AHREs in adults with no prior AF

  This trial tests whether starting rhythm-control therapy plus risk-factor management helps people with device-detected AHREs lasting 6 minutes to 24 hours avoid progressing to clinical atrial fibrillation.

  Recruiting Phase 4 National Taiwan University Hospital · Taipei · NCT07649109

• Catheter ablation plus LAAC vs anticoagulation in frail elderly A-fib patients

  This study tests whether adding left atrial appendage closure to ablation is as good as using long-term blood thinners in frail people aged 75 and up with atrial fibrillation.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT07441382

• Substrate remodelling and targeted ablation for persistent atrial fibrillation

  This project will try using detailed 3D electrical mapping of the left atrium to guide targeted ablation (pulmonary vein reisolation, ganglionic plexi, and substrate ablation) for people with persistent atrial fibrillation undergoing their first catheter ablation.

  Recruiting Barts & The London NHS Trust · London · NCT07047235

• Bad Berka Heart Rhythm Registry for people with or at risk of heart rhythm problems treated at Heart Center Bad Berka

  This registry will collect information from adults with or at risk of heart rhythm problems treated at the Heart Center Bad Berka to see which treatments, devices, and technologies work best and are safest.

  Recruiting Zentralklinik Bad Berka · Bad Berka · NCT07020910

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.